Discovery of biomarker profiles in endometriosis

Recruiting

• Conditions: N80; Endometriosis

• Registration Number: DRKS00034713
• Lead Sponsor: Fraunhofer ITMP-IIP

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2024-07-18
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: Female
• Target Recruitment: 150

Inclusion Criteria

premenopausal women over 18
confirmed/ suspected diagnosis of Endometriosis
signed written consent

Exclusion Criteria

unable to provide consent
current antibiotic treatment
immunosuppression

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
RNA/DNA signatures are determined from the swabs in order to identify possible biomarkers that will facilitate the diagnosis of endometriosis in the future.

Secondary Outcome Measures

Name	Time	Method
protein/ glycoproten signatures and metabolic parameters determined from the swabs in order to identify possible biomarkers that will facilitate the diagnosis of endometriosis in the future.